cobas 4800 BRAF V600 Mutation Test for In Vitro Diagnostic Use Roche Molecular Systems, Inc., ...

FDA Device Recall #Z-0188-2013 — Class III — July 31, 2012

Recall Summary

Recall Number Z-0188-2013
Classification Class III — Low risk
Date Initiated July 31, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Molecular Systems, Inc.
Location Branchburg, NJ
Product Type Devices
Quantity 44 kits

Product Description

cobas 4800 BRAF V600 Mutation Test for In Vitro Diagnostic Use Roche Molecular Systems, Inc., Product Usage: The primary use of the cobas 4800 BRAF V600 Mutation Test is the detection of the BRAF V600 mutations in DNA extracted from formalin-fixed, paraffin-embedded human melanoma tissue. It is intended to be used as an aid in selecting melanoma patients whose tumors carry BRAF V600 mutations for treatment with Zelboraf (vemurafenib).

Reason for Recall

It was identified that BRAF controls dispositioned as "Internal Use Only" were incorrectly packaged into cobas 4800 BRAF V600 Mutation Test CE-IVD kit lot R03607 and released for distribution. Two control batches manufactured during two process validation studies are involved: PV7711: BRAF Mutant (MUT) Control PV0853: BRAF Wild Type (WT) Control

Distribution Pattern

Worldwide Distribution - Australia, Austria, Belgium, China, Hungary, Turkey and United Kingdom.

Lot / Code Information

Material number 05985595190; Lot number R03607

Other Recalls from Roche Molecular Systems, Inc.

Recall # Classification Product Date
Z-1104-2023 Class II cobas SARS-CoV-2 & Influenza A/B Qualitative as... Dec 21, 2022
Z-1106-2023 Class II cobas Influenza A/B & RSV UC (Utility Channel) ... Dec 21, 2022
Z-1105-2023 Class II cobas SARS-CoV-2 & Influenza A/B Qualitative nu... Dec 21, 2022
Z-0097-2023 Class II cobas 5800 instrument, Material No. 08707464001... Sep 8, 2022
Z-0828-2022 Class II cobas LiatSystem, respiratory virus panel nucle... Nov 16, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.